US Broker Ratings

ICON plc (ICLR) Stock Analysis: Unveiling a 31.67% Potential Upside in the Healthcare Sector

ICON plc (NASDAQ: ICLR), a leading player in the healthcare sector, holds a pivotal position in the diagnostics and research industry. Headquartered in Dublin, Ireland, this global clinical research organization..

Quest Diagnostics (DGX) Stock Analysis: Navigating a Tightrope Between Growth and Valuation

For investors with a keen eye on the healthcare sector, Quest Diagnostics Incorporated (NYSE: DGX) presents an intriguing case. As a leading provider in the Diagnostics & Research industry, the..

Ascendis Pharma A/S (ASND) Stock Analysis: Exploring a 29.92% Potential Upside in Biotech

Ascendis Pharma A/S (NASDAQ: ASND), a biopharmaceutical company headquartered in Hellerup, Denmark, is making headlines in the biotechnology sector with its promising pipeline and robust market performance. With a market..

BridgeBio Pharma (BBIO): Investor Outlook with a 32.50% Upside Potential

BridgeBio Pharma, Inc. (NASDAQ: BBIO) is making waves in the biotechnology sector with its promising pipeline of transformative medicines designed to treat genetic diseases and cancers. Based in Palo Alto,..

Agilent Technologies, Inc. (A) Stock Analysis: Exploring the 12.62% Potential Upside in the Healthcare Sector

Agilent Technologies, Inc. (NYSE: A) presents a compelling opportunity for investors with its noteworthy potential upside of 12.62%. As a key player in the healthcare sector, specifically within the diagnostics..

Doximity, Inc. (DOCS) Stock Analysis: Strong Buy Ratings Amid Robust Revenue Growth

Doximity, Inc. (NASDAQ: DOCS) stands out in the healthcare sector as a premier digital platform designed for medical professionals. With a market capitalization of $13.94 billion, Doximity has carved a..

argenx SE (ARGX) Stock Analysis: A Deep Dive into Its 14.84% Upside Potential

argenx SE (NASDAQ: ARGX), a towering presence in the biotechnology sector, continues to captivate investor attention with its compelling growth trajectory. Headquartered in Amsterdam, Netherlands, this commercial-stage biopharma company is..

Fresenius Medical Care AG (FMS) Stock Analysis: Unveiling a 17.29% Potential Upside for Investors

Fresenius Medical Care AG (FMS), a key player in the healthcare sector, specifically within medical care facilities, has been catching the eye of savvy investors. With a market capitalization of..

AbbVie Inc. (ABBV) Stock Analysis: Evaluating Growth Prospects and 3% Potential Upside

AbbVie Inc. (NYSE: ABBV) continues to capture investor attention as a formidable player in the healthcare sector, specifically within the drug manufacturing industry. With a substantial market capitalization of $389.72..

STERIS plc (STE) Stock Analysis: Unveiling a 9.35% Potential Upside for Investors

Investors looking for opportunities in the healthcare sector might find STERIS plc (NYSE: STE) an appealing contender. With its headquarters in Mentor, Ohio, and a market cap of $24.53 billion,..

Corcept Therapeutics (CORT) Investor Outlook: Analyzing a 61% Potential Upside in the Biotech Sector

Corcept Therapeutics Incorporated (NASDAQ: CORT) offers a compelling opportunity for investors seeking exposure in the biotechnology sector, particularly given its robust pipeline of treatments targeting severe endocrinologic, oncologic, metabolic, and..

Summit Therapeutics Inc. (SMMT): Investor Outlook with a 55% Potential Upside

Summit Therapeutics Inc. (NASDAQ: SMMT), a pioneering player in the biotechnology sector, is drawing investor attention with its substantial market cap of $15.56 billion and a notable potential upside of..

Amgen Inc. (AMGN) Stock Analysis: Exploring a 14.17% Upside Potential and Robust Revenue Growth

Amgen Inc. (NASDAQ: AMGN) stands as a beacon in the biopharmaceutical industry, delivering innovative human therapeutics with a market capitalization of $146.96 billion. As an integral player in the healthcare..

AptarGroup, Inc. (ATR) Stock Analysis: Discover Its 33.69% Potential Upside

AptarGroup, Inc. (NYSE: ATR), a leading player in the healthcare sector, specifically within the Medical Instruments & Supplies industry, has been capturing investor attention with a market cap of $8.72..

Bristol-Myers Squibb (BMY) Stock Analysis: Exploring a 20% Upside Potential Amidst Strong Dividend Yield

Bristol-Myers Squibb Company (NYSE: BMY), a stalwart in the healthcare sector, continues to be an intriguing proposition for investors seeking both stability and potential growth in the drug manufacturing industry...

Bio-Techne Corp (TECH) Stock Analysis: 26.65% Potential Upside in the Biotechnology Sector

Bio-Techne Corp (NASDAQ: TECH) stands as a prominent player in the biotechnology sector, commanding a significant presence in the healthcare industry with a market capitalization of $8.07 billion. As a..

Danaher Corporation (DHR) Stock Analysis: Unpacking a 31.76% Potential Upside

As investors seek opportunities in the dynamic healthcare sector, Danaher Corporation (NYSE: DHR) presents a compelling case with a notable potential upside of 31.76%. With a substantial market capitalization of..

Qiagen N.V. (QGEN) Investor Outlook: Assessing the 18% Upside Potential

Qiagen N.V. (NYSE: QGEN), a powerhouse in the Diagnostics & Research industry, headquartered in Venlo, Netherlands, is attracting investor attention with its promising growth prospects and robust market position. With..

Henry Schein, Inc. (HSIC) Stock Analysis: Exploring a Potential 10.85% Upside for Investors

Henry Schein, Inc. (HSIC), a leader in the healthcare sector, stands as a formidable force within the medical distribution industry. Headquartered in Melville, New York, and boasting a market capitalization..

Labcorp Holdings Inc. (LH) Stock Analysis: Navigating Growth and Investor Confidence

Labcorp Holdings Inc. (NYSE: LH), a prominent player in the healthcare sector’s Diagnostics & Research industry, stands as a leading provider of laboratory services. With a market capitalization of $23.32..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds